Description:
Prescription required for orders
placed from the USA
NeoVisc is a 1.0%
solution of highly purified Sodium Hyaluronate. In the
joint Hyaluronate provides the viscoelasticity (lubrication)
of synovial fluid and the resilience and elastic strength
(cushioning effect) to cartilage. NeoVisc works as a
viscosupplement by improving the natural viscosity and
elasticity of synovial fluid, thereby increasing lubrication,
improved joint mobility and a reduction of
pain.
Indications/Usage:
NeoVisc
is administered by your physician through a series of
intraarticular injections (injections into the synovial space
of the joint). One injection per week, over a 15 day period
for a total of three (3) injections. Onset of symptomatic
relief varies from patient to patient depending on severity of
OA. Some experience improvement after the second injection,
while optimal results are usually seen 15 to 30 days after the
last injection.
It
is believed that a course of viscosupplementation with
NeoVisc (Hyaluronate), stimulates cells in joint
tissues to produce their own healthy hyaluronate, extending
the therapeutic benefit for an average of 6 to 12
months.
Patients
with more severe osteoarthritis may gain greater benefit from
a series of five (5) weekly NeoVisc injections. Consult with
your physician.
Side
Effects:
Hyaluronate is a
natural component of synovial fluid and there have been no
significant adverse reactions attributable to the highly
purified Sodium Hyaluronate used in NeoVisc. However, as with
any injection, there may be the occurrence of transient pain
at the injection site. Should the injected joint remain
painful for more than twelve (12) hours or become swollen,
contact your physician immediately.
Precautions:
No
excessive or strenuous activity for the first 24 hours after
your injection. At the first signs of your OA symptoms
reappearing, call your physician to book another course of
NeoVisc injections.
Call
toll free 1.866.828.3484 for current market price or to place
an order.